Please assess the completion status of the following clinical trial:

Trial Title: Beta-hCG Test Reference Range Determination

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Apparently healthy, non-pregnant females, of any race.~2. \>18 years of age.~3. Willing to voluntarily agree to sign a consent form.~Exclusion Criteria:~1. Current pregnancy, suspected pregnancy, or pregnancy within previous 12 months.~2. Currently lactating/nursing a child.~3. Current diagnosis of Gestational Trophoblastic Disease, Gestational Trophoblastic Tumor or Gestational Trophoblastic Neoplasia.~4. Current diagnosis of non-trophoblastic tumors.~5. Current diagnosis of cancer and/or has undergone immunotherapy in the previous 12 months.~6. Current diagnosis of a serious health condition that involves inpatient care or continuing treatment by a health care provider, such as:~   * Conditions or treatments that result in continuous or episodic incapacity (e.g. pneumonia, epilepsy).~  * Permanent or long-term conditions (e.g. HIV, Alzheimer's, severe stroke).~  * Conditions requiring multiple treatment/recovery cycles (e.g. kidney disease).~7. Hospitalization (for \>24 hours) or major surgery within previous 3 months.~8. Unable, or unwilling, to provide required blood sample for testing.~9. Investigator believes subject is unsuitable for inclusion in the trial (i.e. has serious condition(s) or other reason(s) that could limit their ability to participate in the study; or impact the scientific integrity of the study).

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).